HedgeCo.Net — The Special Committee of Definitive Healthcare Corp. (Nasdaq: DH) on September 2, 2026 confirmed receipt of a non-binding indication of interest dated September 1, 2026 from Advent International L.P., on behalf of funds it manages. Business Insider’s markets wire carried the Special Committee confirmation. StockTitan independently surfaced the related Schedule 13D / major-shareholder acquisition filing context on DH.
The proposal is an all-cash $1.02 per Class A share and an equivalent per AIDH TopCo LLC OpCo unit for interests not already owned by Advent or by founder and Executive Chairman Jason Krantz. The indication assumes Krantz rolls equity into the surviving company. A Special Committee of disinterested independent directors is reviewing the proposal with independent advisors. No stockholder action is required at this stage, there is no binding obligation to consummate a transaction, and Advent may modify or withdraw the proposal.
This is a non-binding indication of interest, not a signed merger agreement and not a closed take-private. Mark $1.02 cash as the proposed price, September 1 as the indication date, and September 2 as the Special Committee confirmation. Do not invent a premium to the undisturbed share price, a financing package, or a close timetable that is not in these sources. The allocator object is Advent testing a going-private path on DH while already on the cap table alongside a founder roll assumed in the proposal.